Letters to the Editor

Glenzocimab does not impact glycoprotein VI-dependent inflammatory haemostasis

Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris, France; Rothschild Foundation Hospital, Paris, France. Department of Interventional Neuroradiology.
Université de Paris, LVTS, Inserm U1148, F-75018 Paris, France; Rothschild Foundation Hospital, Paris, France. Department of Interventional Neuroradiology.
University Hospital Würzburg, Rudolf Virchow Center for Experimental Biomedicine, Würzburg
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S1255, FMTS, F-67065 Strasbourg, France
Université de Paris, LVTS, Inserm U1148, F-75018 Paris
Haematologica Early view Dec 30, 2020 https://doi.org/10.3324/haematol.2020.270439